ITOS - Prakiraan volume dodolan iTeos Therapeutics
The absence of current revenue streams makes iTeos Therapeutics (ITOS) dependent on previous partner payments. However, management's financial discipline and support from GSK have ensured a significant liquidity cushion. The target sales volume reflects capital preservation dynamics, where the current figure stands at 0.00. Looking ahead, revenue growth is predicated on the commercial success of innovative oncology drugs.
Ringkesan rincian data analitis iTeos Pharma (ITOS)
- nilai saham lan prakiraan konsensus rega:
- statistik kapitalisasi pasar:
- informasi kapitalisasi buku:
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal iTeos Therapeutics|ITOS - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas iTeos Therapeutics Inc|ITOS - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku iTeos Therapeutics, Inc.|ITOS - Gunggunge utang jangka dawa|Kewajiban jangka cendhak perusahaan iTeos Therapeutics|Indikator likuiditas cepet iteostherapeutics.com
- statistik bathi lan rasio pasar:
ITOS - Bathi sawise mbayar pajeg|Proyeksi bathi mangsa ngarep iTeos Therapeutics|ITOS - Nilai perusahaan marang bathi resik|Pangali Forward P/E iteostherapeutics.com|ITOS - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan iTeos Therapeutics|ITOS - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) iTeos Therapeutics|ITOS - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan iteostherapeutics.com|ITOS - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep iTeos Therapeutics
- data pendapatan lan penerimaan dodolan:
Analisis kabeh metrik perusahaan:ITOS iTeos Therapeutics Inc
iTeos Therapeutics (ITOS) maintains a strong position due to inelastic demand for its unique TIGIT inhibitors. Analyzing the company's sales volume trend allows for the tracking of the market's real-time revaluation of the business. The current value of 0.00 reflects the dynamics of consensus forecasts, separating fundamental shifts from short-term noise. This indicator measures the change in the issuer's index weight through the prism of future cash flows. The rising metric confirms investors' long-term faith in the commercial success of belarestugut.
Pesaing utama
Prakiraan pendapatan perusahaan Argenx (ARGX)|BioNTech - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan ABVX (Abivax)|ADMA Bio (ADMA) - Volume dodolan sing dikarepake perusahaan|PTGX - Prakiraan pendapatan perusahaan|Dodolan mangsa ngarep perusahaan immunovant.com IMVT|KNSA: Prakiraan volume dodolan|Grifols - Pendapatan mangsa ngarep perusahaan|ADPT (Adaptive Biotech) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan CLDX|Prakiraan volume dodolan AUPH|Volume dodolan mangsa ngarep perusahaan biocryst.com BCRX|Vera Therapeutics - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume pendapatan perusahaan DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV - Prakiraan volume dodolan|ABCL: Prakiraan pendapatan perusahaan|Tourmaline Bio, Inc. (TRML) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan precigen.com (PGEN)|PHAR (pharming.com) - Prakiraan volume dodolan|NKTR (Nektar Therapeutics Inc.) - Prakiraan volume pendapatan perusahaan|Prakiraan volume dodolan UPB|ZBIO - Volume dodolan sing dikarepake perusahaan|Prakiraan volume dodolan IMNM (immunome.com)|Gossamer Bio, Inc. - Prakiraan pendapatan perusahaan|KalVista Pharmaceuticals, Inc. - Prakiraan volume dodolan|SEPN (Septerna) - Prakiraan pendapatan perusahaan|Pieris Corp (PVLA) - Prakiraan pendapatan perusahaan|SVRA - Dodolan mangsa ngarep perusahaan|RIGL (rigel.com) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan ANAB (AnaptysBio, Inc.)|Prakiraan volume dodolan ATXS|enGene Holdings Inc (ENGN) - Prakiraan dodolan perusahaan|Prakiraan volume dodolan RAPT (RAPT Therapeutics Inc.)|JBIO (Aerovate) - Pendapatan sing dikarepake perusahaan|ACRS: Volume dodolan mangsa ngarep perusahaan|KYTX - Prakiraan volume dodolan|TLSA: Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan Cabaletta Bio, Inc|Prakiraan pendapatan perusahaan Ventyx Biosciences, Inc|THTX: Pendapatan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan AVTX (Avalo Therapeutics, Inc)|Volume dodolan mangsa ngarep perusahaan Eledon Pharmaceuticals ELDN|Prakiraan pendapatan perusahaan Agenus, Inc. AGEN|Prakiraan volume dodolan Climb Bio Inc. CLYM|ZURA - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan ATYR|ADAG (Adagene Inc.) - Volume dodolan mangsa ngarep perusahaan|ImageneBio Inc (IMA) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan Shattuck Therapeutics|Volume dodolan mangsa ngarep perusahaan equilliumbio.com (EQ)|Prakiraan volume dodolan CNTB|Dodolan mangsa ngarep perusahaan Immunic Therapeutics|Prakiraan volume dodolan ATRA (Atara Biotherapeutics, Inc.)|IFRX - Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan X4 Pharmaceuticals, Inc. (XFOR)|ACET (adicetbio.com) - Prakiraan pendapatan perusahaan|CELU: Prakiraan volume dodolan|INMB - Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Barinthus Biotherapeutics plc|KZR: Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan SABS|AKTX (Akari Therapeutics Plc) - Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan ENLV (Enlivex Therapeutics Ltd)|q32bio.com - Prakiraan pendapatan perusahaan|GOVX: Volume dodolan mangsa ngarep perusahaan|edesabiotech.com (EDSA) - Volume dodolan mangsa ngarep perusahaan|IBIO: Prakiraan volume dodolan|CARM - Dodolan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan XTLB|Volume dodolan mangsa ngarep perusahaan boltbio.com (BOLT)|Prakiraan pendapatan perusahaan HCW Biologics Inc (HCWB)|Prakiraan volume dodolan Aptevo Therapeutics, Inc. (APVO)|Prakiraan pendapatan perusahaan aimimmuno.com AIM|Pendapatan mangsa ngarep perusahaan ADTX|GRI Bio Corporation - Prakiraan volume dodolan|XORTX Corp (XRTX) - Volume dodolan mangsa ngarep perusahaan|HIND (Vyome Holdings Inc.) - Volume dodolan mangsa ngarep perusahaan|revbiosciences.com (REVB) - Prakiraan volume dodolan|INDP (Indaptus Corp) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan Scinai Immunotherapeutics Ltd (SCNI)|Prakiraan pendapatan perusahaan CalciMedica Inc (CALI)|AFMD (Affimed NV) - Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan ALLK (Allakos Inc.)|Prakiraan volume dodolan HOOKIPA HOOK|IGMS: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan Ocean Biomedical|TCBP: Prakiraan volume dodolan|Third Harmonic Bio, Inc - Pendapatan mangsa ngarep perusahaan
